Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
€30,251.81
% of Total Estimate Gain
20.53%

RBC International Small Cap Equity Fund's Laboratorios Farmaceuticos Rovi SA Holding Summary

As of 2025-03-31, RBC International Small Cap Equity Fund held - shares of Laboratorios Farmaceuticos Rovi SA(XMAD:ROVI), totaling N/A. This investment constitutes 0% of their stock portfolio, and RBC International Small Cap Equity Fund now holds 0% of the outstanding Laboratorios Farmaceuticos Rovi SA(XMAD:ROVI) stock.

The initial trade took place in 2022Q4. And since then RBC International Small Cap Equity Fund has made 2 purchases of XMAD:ROVI, at an average price of €41.83, for a total of 3,522.00 shares. In addition, there have been 3 sales at an average price of €50.42 for 3,522.00 shares. Based on historical transaction data and XMAD:ROVI's current price of €55.70, RBC International Small Cap Equity Fund's estimated gain on his XMAD:ROVI holdings is €30,251.81, reflecting a 20.53% gain to date.

RBC International Small Cap Equity Fund XMAD:ROVI (€55.70) Holding Chart

RBC International Small Cap Equity Fund XMAD:ROVI (€55.70) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price €-/Share
Shares Sold 0 Average Price €-/Share
Current Price €0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1